| Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... New England Journal of Medicine 375 (5), 443-453, 2016 | 1595 | 2016 |
| PAGE VIEWS J Zhang, MF Walsh, G Wu N Engl J Med 2016 (374), 1390-1391, 2016 | 1288* | 2016 |
| Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline biallelic mismatch repair deficiency E Bouffet, V Larouche, BB Campbell, D Merico, R De Borja, M Aronson, ... Journal of clinical oncology 34 (19), 2206-2211, 2016 | 842 | 2016 |
| The genomic landscape of hypodiploid acute lymphoblastic leukemia L Holmfeldt, L Wei, E Diaz-Flores, M Walsh, J Zhang, L Ding, ... Nature genetics 45 (3), 242-252, 2013 | 787 | 2013 |
| Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, ... JCO precision oncology 1, 1-16, 2017 | 516 | 2017 |
| Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, ... Journal of clinical oncology 37 (4), 286, 2019 | 510 | 2019 |
| Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, ... Jama 318 (9), 825-835, 2017 | 459 | 2017 |
| The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes R Huether, L Dong, X Chen, G Wu, M Parker, L Wei, J Ma, MN Edmonson, ... Nature communications 5 (1), 3630, 2014 | 411 | 2014 |
| Germline variants in targeted tumor sequencing using matched normal DNA KA Schrader, DT Cheng, V Joseph, M Prasad, M Walsh, A Zehir, A Ni, ... JAMA oncology 2 (1), 104-111, 2016 | 326 | 2016 |
| Telomere length is a determinant of emphysema susceptibility JK Alder, N Guo, F Kembou, EM Parry, CJ Anderson, AI Gorgy, MF Walsh, ... American journal of respiratory and critical care medicine 184 (8), 904-912, 2011 | 294 | 2011 |
| Retinoblastoma and neuroblastoma predisposition and surveillance J Kamihara, F Bourdeaut, WD Foulkes, JJ Molenaar, YP Mossé, ... Clinical Cancer Research 23 (13), e98-e106, 2017 | 207 | 2017 |
| The genomic landscape of pediatric myelodysplastic syndromes JR Schwartz, J Ma, T Lamprecht, M Walsh, S Wang, V Bryant, G Song, ... Nature communications 8 (1), 1557, 2017 | 185 | 2017 |
| Conflicting interpretation of genetic variants and cancer risk by commercial laboratories as assessed by the prospective registry of multiplex testing J Balmaña, L Digiovanni, P Gaddam, MF Walsh, V Joseph, ZK Stadler, ... Journal of Clinical Oncology 34 (34), 4071, 2016 | 181 | 2016 |
| Cancer surveillance in Gorlin syndrome and rhabdoid tumor predisposition syndrome WD Foulkes, J Kamihara, DGR Evans, L Brugières, F Bourdeaut, ... Clinical Cancer Research 23 (12), e62-e67, 2017 | 180 | 2017 |
| Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome M Rusch, J Nakitandwe, S Shurtleff, S Newman, Z Zhang, MN Edmonson, ... Nature communications 9 (1), 3962, 2018 | 175 | 2018 |
| Baseline surveillance in Li-Fraumeni syndrome using whole-body magnetic resonance imaging: a meta-analysis ML Ballinger, A Best, PL Mai, PP Khincha, JT Loud, JA Peters, MI Achatz, ... JAMA oncology 3 (12), 1634-1639, 2017 | 171 | 2017 |
| Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia PLoS genetics, 2015 | 167 | 2015 |
| Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma MI Carlo, S Mukherjee, D Mandelker, J Vijai, Y Kemel, L Zhang, ... JAMA oncology 4 (9), 1228-1235, 2018 | 156 | 2018 |
| Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk A Villani, MLC Greer, JM Kalish, A Nakagawara, KL Nathanson, ... Clinical Cancer Research 23 (12), e83-e90, 2017 | 154 | 2017 |
| Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms BH Durham, E Lopez Rodrigo, J Picarsic, D Abramson, V Rotemberg, ... Nature medicine 25 (12), 1839-1842, 2019 | 147 | 2019 |
Jonathan K. Alder, Ph.D.Associate Professor, University of Pittsburgh School of Medicine在 pitt.edu 的电子邮件经过验证
Jonathan K. Alder, Ph.D.Associate Professor, University of Pittsburgh School of Medicine在 pitt.edu 的电子邮件经过验证